P. Antonoaea, N. Todoran, E. Rédai, R. Vlad, M. Bîrsan, Aura Rusu, A. Ciurba, I. Pharmacy
{"title":"布洛芬在当前社区药房执业药师中的应用","authors":"P. Antonoaea, N. Todoran, E. Rédai, R. Vlad, M. Bîrsan, Aura Rusu, A. Ciurba, I. Pharmacy","doi":"10.37897/RJPHP.2020.3.1","DOIUrl":null,"url":null,"abstract":"The pharmacist from the community pharmacy plays a key role in the case of patients who seek directly for pathologies related to pain. Being a health specialist, he has the ability to offer pharmaceutical healthcare for drugs that need a medical prescription and also for the ones that are registered as OTC’s. Ibuprofen (IBU) is a part of the drug group called nonsteroidal anti-inflammatory drugs (NSAIDs) being registered in Romania under 17 pharmaceutical formulation by the National Agency of Drugs and Medical Devices. Due to its pharmacological profile which consists of a low risk of gastro intestinal side effects, IBU is an OTC recommended and frequently prescribed for decreasing the low and moderate pain. World Health Organization (WHO) indicates IBU as a drug that can be used to babies aged over three months. Through this paper, we try to analyze the pharmacist’s vision from the community pharmacy in IBU recommendation. In this paper were mentioned some legal aspects that are linked to the pharmacist competences, and also its approach regarding IBU recommendation during pregnancy and breastfeeding and also to children and to a category of patients who have various associated pathologies.","PeriodicalId":33513,"journal":{"name":"Practica Farmaceutica","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ibuprofen in the current practice of the pharmacist in the community pharmacy\",\"authors\":\"P. Antonoaea, N. Todoran, E. Rédai, R. Vlad, M. Bîrsan, Aura Rusu, A. Ciurba, I. Pharmacy\",\"doi\":\"10.37897/RJPHP.2020.3.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The pharmacist from the community pharmacy plays a key role in the case of patients who seek directly for pathologies related to pain. Being a health specialist, he has the ability to offer pharmaceutical healthcare for drugs that need a medical prescription and also for the ones that are registered as OTC’s. Ibuprofen (IBU) is a part of the drug group called nonsteroidal anti-inflammatory drugs (NSAIDs) being registered in Romania under 17 pharmaceutical formulation by the National Agency of Drugs and Medical Devices. Due to its pharmacological profile which consists of a low risk of gastro intestinal side effects, IBU is an OTC recommended and frequently prescribed for decreasing the low and moderate pain. World Health Organization (WHO) indicates IBU as a drug that can be used to babies aged over three months. Through this paper, we try to analyze the pharmacist’s vision from the community pharmacy in IBU recommendation. In this paper were mentioned some legal aspects that are linked to the pharmacist competences, and also its approach regarding IBU recommendation during pregnancy and breastfeeding and also to children and to a category of patients who have various associated pathologies.\",\"PeriodicalId\":33513,\"journal\":{\"name\":\"Practica Farmaceutica\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Practica Farmaceutica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37897/RJPHP.2020.3.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Practica Farmaceutica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37897/RJPHP.2020.3.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
社区药房的药剂师在直接寻求疼痛相关病理的患者中起着关键作用。作为一名健康专家,他有能力为需要医疗处方的药物以及注册为OTC的药物提供药物保健。布洛芬(IBU)是罗马尼亚国家药品和医疗器械管理局(National Agency of drugs and Medical Devices)在17种药物配方下注册的非甾体类抗炎药(NSAIDs)的一部分。由于其药理特征包括低风险的胃肠道副作用,IBU是一种推荐的非处方药,经常用于减少轻度和中度疼痛。世界卫生组织(WHO)指出,IBU是3个月以上婴儿可以使用的药物。通过本文,我们试图从社区药房在IBU推荐中分析药师的愿景。在本文中提到了一些与药剂师能力相关的法律方面,以及在怀孕和哺乳期间以及对儿童和具有各种相关病理的患者推荐IBU的方法。
Ibuprofen in the current practice of the pharmacist in the community pharmacy
The pharmacist from the community pharmacy plays a key role in the case of patients who seek directly for pathologies related to pain. Being a health specialist, he has the ability to offer pharmaceutical healthcare for drugs that need a medical prescription and also for the ones that are registered as OTC’s. Ibuprofen (IBU) is a part of the drug group called nonsteroidal anti-inflammatory drugs (NSAIDs) being registered in Romania under 17 pharmaceutical formulation by the National Agency of Drugs and Medical Devices. Due to its pharmacological profile which consists of a low risk of gastro intestinal side effects, IBU is an OTC recommended and frequently prescribed for decreasing the low and moderate pain. World Health Organization (WHO) indicates IBU as a drug that can be used to babies aged over three months. Through this paper, we try to analyze the pharmacist’s vision from the community pharmacy in IBU recommendation. In this paper were mentioned some legal aspects that are linked to the pharmacist competences, and also its approach regarding IBU recommendation during pregnancy and breastfeeding and also to children and to a category of patients who have various associated pathologies.